The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Concordance among gene-expression-based predictors for ER-positive breast cancer treated with adjuvant tamoxifen.
A. Prat
No relevant relationships to disclose
J. S. Parker
No relevant relationships to disclose
C. Fan
No relevant relationships to disclose
M. C. U. Cheang
No relevant relationships to disclose
L. D. Miller
No relevant relationships to disclose
J. Bergh
No relevant relationships to disclose
S. K. L. Chia
No relevant relationships to disclose
P. S. Bernard
Employment or Leadership Position - University Genomics (U)
Stock Ownership - Bioclassifier
T. O. Nielsen
Stock Ownership - Bioclassifier
M. J. Ellis
Employment or Leadership Position - University Genomics (U)
Stock Ownership - Bioclassifier
L. A. Carey
No relevant relationships to disclose
C. M. Perou
Employment or Leadership Position - University Genomics (U)
Stock Ownership - Bioclassifier